NCT06681363View on ClinicalTrials.gov

Creation of a Biocollection of Patients with Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored At the Nantes University Hospital

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

November 15, 2034

Study Completion Date

November 15, 2034

Conditions

Acute Myeloid LeucemiaHigh-risk Myelodysplastic Syndrome (MDS)Acute Lymphoid Leukemia

Trial Locations (1)

Unknown

Nantes University Hospital, Nantes

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT06681363 - Creation of a Biocollection of Patients with Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored At the Nantes University Hospital | Biotech Hunter | Biotech Hunter